AOD9604 duration claims: what the evidence actually supports

What did @livv.peptides actually say?

The creator recommends taking AOD-9604 for "three months to six months," with doses ranging from "20 units to 30 units," and says you can extend use to a year with blood work monitoring. This is a fairly specific protocol recommendation delivered to an audience of over 123,000 viewers, which means it deserves a close look.

The framing here matters. The creator positions this as clinical guidance, using language like "I typically recommend patients," which implies a practitioner relationship. Whether that context applies to everyone watching a TikTok is a different question entirely. The dose figure of 20 to 30 units is presented casually, without specifying the concentration of the solution being used, which makes that number clinically meaningless without more context.

Does the science back this up?

The honest answer: not really, at least not for the claims being made here. AOD-9604 has a real but limited research history, and the gap between what the studies show and what peptide content creators say is wide.

AOD-9604 is a synthetic peptide fragment derived from the C-terminus of human growth hormone (amino acids 176-191). Early animal studies, including work by Heffernan et al. (2001, Journal of Endocrinology), showed promising lipolytic effects in rodent models. That generated significant excitement. Then came the human trials. Ng et al. (2000, Journal of Clinical Endocrinology and Metabolism) and subsequent Phase IIb and Phase III trials conducted by Metabolic Pharmaceuticals found that AOD-9604 did not produce statistically significant weight loss compared to placebo in obese human subjects. The drug failed to gain FDA approval for obesity. No long-term human safety data exists for the three-to-six-month or one-year windows the creator recommends. The "typical fat burning peptide" framing is getting ahead of the evidence by a considerable distance.

What did they get wrong (or right)?

Credit where it is due: recommending blood work monitoring is genuinely reasonable advice, and it is more responsible than many peptide influencers who skip that part entirely. The suggestion to "understand where your levels are changing" reflects at least some awareness that peptide use warrants clinical oversight.

However, several things are problematic here. First, stating a specific dose range of "20 units to 30 units" without specifying concentration is either an oversight or an assumption that the audience already has a standardized product, which they may not. Compounded AOD-9604 varies in concentration across suppliers. Second, the three-to-six-month duration recommendation is not derived from any published clinical trial in humans. There is no peer-reviewed study supporting that timeline as a safe or effective window for fat loss. Third, characterizing AOD-9604 as a reliable fat burning tool contradicts the outcome of its own pivotal human clinical trials. The Metabolic Pharmaceuticals trials specifically failed to replicate animal results in humans at multiple dose levels.

What should you actually know?

AOD-9604 is not FDA-approved for any indication. It is available as a compounded peptide through some telehealth providers, but that availability does not equal proven efficacy or established safety for multi-month use. The FDA placed AOD-9604 on its list of bulk drug substances that may not be used in compounding in 2022, citing insufficient clinical evidence, though enforcement and access vary by jurisdiction.

If you are considering AOD-9604, the relevant questions are not how many units to inject or how many months to run it. The relevant questions are whether your provider has reviewed your full metabolic panel, whether the compounding pharmacy is accredited, and whether the claimed fat loss benefit justifies the unknown risk profile for long-term use. A 2023 review by Raun et al. in Peptides noted that extrapolating rodent lipolytic data to human fat metabolism has repeatedly failed across multiple GH-derived peptide fragments. That pattern should inform any decision here.